Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

Automated insulin was linked to more time in range in adults with type 1 diabetes

☕ Includes a question for the family ↓

Type 1 diabetesPart of a story we are following · 5 articles · See every update
A man cycles over a bridge with a river and apartment towers behind him in Recife, Brazil.
A man cycles over a bridge with a river and apartment towers behind him in Recife, Brazil.Photo: Wilfredor / Wikimedia Commons, CC0

If you or someone you love lives with type 1 diabetes, here is what a new study found about automated insulin systems: the changes showed up fast and were still there a year later. In a study of 132 adults with type 1 diabetes in Saudi Arabia, people who started an automated insulin delivery system spent more of the day in their target glucose range and far less time too low, and both changes were still seen at 12 months.

Starting the systems was also linked to lower A1c numbers and fewer serious events, such as severe lows and a dangerous complication called diabetic ketoacidosis.

How the study worked

Researchers followed 132 adults with type 1 diabetes for 12 months after they started either the Control-IQ system (76 people) or the MiniMed 780G system (56 people) at a hospital diabetes center in Riyadh, Saudi Arabia, between December 2023 and November 2025. The results were published on November 19, 2026 in the J Diabetes Sci Technol; because everyone chose a system and was compared with their own starting point, this study shows a link rather than proof of cause, and it comes from a single center.

The average age was about 27 years (27.2), and about 69% of the group (68.9%) were women. On average, people had lived with diabetes for about 14 years (14.5).

What are time in range and time below range?

Most people with type 1 diabetes wear a continuous glucose monitor, or CGM. It is a small sensor that tracks your glucose all day and night.

“Time in range” is the share of the day your glucose stays between 70 and 180 mg/dL. More is better. “Time below range” is the share of the day you spend under 70 mg/dL, which is when lows happen. Less is better.

What they found

Time in range rose from about 59% (59.0%) before starting to about 72% (72.3%) after just 2 weeks. It stayed up at 12 months, at 73.5%.

The number of people hitting a common goal of spending at least 70% of the day in range went from 29.0% to 71.0%.

Lows dropped too. Time below 70 mg/dL went from about 5% of the day (5.3%) to about 1% (1.4%).

A1c, the blood test that reflects your average glucose over a few months, went from 7.42% to 6.52% in the 106 people who had both a before and an after test. The share of people with an A1c under 7% rose from 30.3% to 74.5%.

The researchers also report that rates of severe low blood sugar and of diabetic ketoacidosis were significantly lower after people started the systems.

The gains did not fade after the first few weeks. That matters, because many people worry that a new tool works well at first and then loses its edge.

What you can do today

If you already wear a CGM, open its app or report today and find two numbers for the last 2 weeks: your time in range (70 to 180 mg/dL) and your time below 70 mg/dL. Write them down and bring them to your next diabetes visit, so you can ask your care team whether an automated insulin system could be a fit for you.

For clinicians and researchers

Design: Prospective observational cohort of 132 adults with type 1 diabetes (mean age 27.2 ± 7.7 years, 68.9% female) starting Control-IQ (n = 76) or MiniMed 780G (n = 56) at King Fahad Medical City, Riyadh, followed 12 months; baseline served as comparator.

Main result: Time in range rose from 59.0 ± 15.4% at baseline to 73.5 ± 11.5% at 12 months (+15.1 percentage points; P < .001). HbA1c fell from 7.42 ± 1.13 to 6.52 ± 0.73% (P < .001; n = 106).

Main limitation: Single-center observational design without a concurrent control group, so improvements cannot be attributed causally to automated insulin delivery; HbA1c was available for 106 of 132 participants.

Open question: Whether these gains persist beyond 12 months and how the two systems compare head to head remain to be tested in controlled or larger multicenter studies.

Talk about it at home

Our bodies run on a kind of fuel from food called glucose, and it works best when the amount stays in a comfortable middle zone, not too high and not too low. Scientists followed a group of adults who started using a smart system that reads their fuel level all day and adjusts by itself, and they checked how it was going after a whole year. It works a bit like the thermostat at home, which keeps a room cozy by turning the heat up and down without anyone touching it.

Try it at home

Try balancing a pencil or a ruler flat on your finger and keep it steady as long as you can. Notice how your eyes and your hand make tiny adjustments all the time, a lot like a smart system keeping things steady, and see who at the table can last the longest.

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. Automated insulin was linked to more time in range in adults with type 1 diabetes. Mongevity. Published November 21, 2026. Accessed November 22, 2026. https://mongevity.science/metabolism/2026/11/type-1-diabetes-automated-insulin-12-months-time-in-range/
Vancouver
Mongevity Desk. Automated insulin was linked to more time in range in adults with type 1 diabetes [Internet]. Mongevity; 2026 Nov 21 cited 2026 Nov 22]. Available from: https://mongevity.science/metabolism/2026/11/type-1-diabetes-automated-insulin-12-months-time-in-range/
APA
Mongevity Desk. (2026, November 21). Automated insulin was linked to more time in range in adults with type 1 diabetes. Mongevity. https://mongevity.science/metabolism/2026/11/type-1-diabetes-automated-insulin-12-months-time-in-range/
For your website
<a href="https://mongevity.science/metabolism/2026/11/type-1-diabetes-automated-insulin-12-months-time-in-range/">Automated insulin was linked to more time in range in adults with type 1 diabetes</a>

Free to share or quote with credit and a link.

Questions and answers

What is automated insulin delivery?
It is an insulin system, such as Control-IQ or MiniMed 780G, that delivers insulin automatically for people with type 1 diabetes. Both were used in this study.
How long did the improvements last?
People were followed for 12 months. Time in range rose within 2 weeks and was still 73.5% at the 12-month mark.
What is time in range?
It is the share of the day your glucose stays between 70 and 180 mg/dL, as measured by a continuous glucose monitor.
Does this prove the systems caused the improvements?
No. It followed 132 adults without a comparison group, so it shows a strong link rather than proof of cause.

Sources

  1. J Diabetes Sci Technol: Sustained Improvement in Time in Range After Automated Insulin Delivery Initiation in Adolescents and Adults With Type 1 Diabetes Mellitus: A 12-Month Prospective Observational Study From Saudi Arabia (PMID 43055124 · DOI 10.1177/19322968261502745) · 2026-11-21

More on this story

Report an error